These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18032109)

  • 21. Poly (ADP-ribose) polymerase-1 (PARP-1) as immune regulator.
    Laudisi F; Sambucci M; Pioli C
    Endocr Metab Immune Disord Drug Targets; 2011 Dec; 11(4):326-33. PubMed ID: 21476963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke.
    Yuan M; Siegel C; Zeng Z; Li J; Liu F; McCullough LD
    Exp Neurol; 2009 May; 217(1):210-8. PubMed ID: 19268668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.
    Teng F; Beray-Berthat V; Coqueran B; Lesbats C; Kuntz M; Palmier B; Garraud M; Bedfert C; Slane N; Bérézowski V; Szeremeta F; Hachani J; Scherman D; Plotkine M; Doan BT; Marchand-Leroux C; Margaill I
    Exp Neurol; 2013 Oct; 248():416-28. PubMed ID: 23876515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors.
    Tentori L; Portarena I; Graziani G
    Pharmacol Res; 2002 Feb; 45(2):73-85. PubMed ID: 11846617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor, ameliorates ischemic brain damage in a non-human primate model.
    Matsuura S; Egi Y; Yuki S; Horikawa T; Satoh H; Akira T
    Brain Res; 2011 Sep; 1410():122-31. PubMed ID: 21741620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and Evaluation of a Mitochondria-Targeting Poly(ADP-ribose) Polymerase-1 Inhibitor.
    Krainz T; Lamade AM; Du L; Maskrey TS; Calderon MJ; Watkins SC; Epperly MW; Greenberger JS; Bayır H; Wipf P; Clark RSB
    ACS Chem Biol; 2018 Oct; 13(10):2868-2879. PubMed ID: 30184433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial impairment induced by poly(ADP-ribose) polymerase-1 activation in cortical neurons after oxygen and glucose deprivation.
    Tanaka S; Takehashi M; Iida S; Kitajima T; Kamanaka Y; Stedeford T; Banasik M; Ueda K
    J Neurochem; 2005 Oct; 95(1):179-90. PubMed ID: 16181422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion.
    Hamby AM; Suh SW; Kauppinen TM; Swanson RA
    Stroke; 2007 Feb; 38(2 Suppl):632-6. PubMed ID: 17261705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(ADP-ribose) polymerase-1 inhibition increases expression of heat shock proteins and attenuates heat stroke-induced liver injury.
    Mota RA; Hernández-Espinosa D; Galbis-Martinez L; Ordoñez A; Miñano A; Parrilla P; Vicente V; Corral J; Yélamos J
    Crit Care Med; 2008 Feb; 36(2):526-34. PubMed ID: 18091544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death.
    Kauppinen TM; Swanson RA
    J Immunol; 2005 Feb; 174(4):2288-96. PubMed ID: 15699164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats.
    Nakajima H; Kakui N; Ohkuma K; Ishikawa M; Hasegawa T
    J Pharmacol Exp Ther; 2005 Feb; 312(2):472-81. PubMed ID: 15466246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural inhibitors of poly(ADP-ribose) polymerase-1.
    Banasik M; Stedeford T; Strosznajder RP
    Mol Neurobiol; 2012 Aug; 46(1):55-63. PubMed ID: 22476980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
    Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
    Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(ADP-ribose) polymerase inhibition protect neurons and the white matter and regulates the translocation of apoptosis-inducing factor in stroke.
    Komjáti K; Mabley JG; Virág L; Southan GJ; Salzman AL; Szabó C
    Int J Mol Med; 2004 Mar; 13(3):373-82. PubMed ID: 14767566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(ADP-ribose)polymerases inhibitors prevent early mitochondrial fragmentation and hepatocyte cell death induced by H2O2.
    Martín-Guerrero SM; Muñoz-Gámez JA; Carrasco MC; Salmerón J; Martín-Estebané M; Cuadros MA; Navascués J; Martín-Oliva D
    PLoS One; 2017; 12(10):e0187130. PubMed ID: 29073231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poly(ADP-ribose): PARadigms and PARadoxes.
    Bürkle A; Virág L
    Mol Aspects Med; 2013 Dec; 34(6):1046-65. PubMed ID: 23290998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poly (ADP-ribose) polymerase, nitric oxide and cell death.
    Pieper AA; Verma A; Zhang J; Snyder SH
    Trends Pharmacol Sci; 1999 Apr; 20(4):171-81. PubMed ID: 10322503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
    Dantzer F; Amé JC; Schreiber V; Nakamura J; Ménissier-de Murcia J; de Murcia G
    Methods Enzymol; 2006; 409():493-510. PubMed ID: 16793420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying Direct Protein Targets of Poly-ADP-Ribose Polymerases (PARPs) Using Engineered PARP Variants-Orthogonal Nicotinamide Adenine Dinucleotide (NAD+) Analog Pairs.
    Carter-O'Connell I; Cohen MS
    Curr Protoc Chem Biol; 2015 Jun; 7(2):121-39. PubMed ID: 26344237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor.
    Yu SW; Wang H; Poitras MF; Coombs C; Bowers WJ; Federoff HJ; Poirier GG; Dawson TM; Dawson VL
    Science; 2002 Jul; 297(5579):259-63. PubMed ID: 12114629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.